ACRS
Aclaris Therapeutics Inc.
Company Overview
| Mkt Cap | $258.91M | Price | $2.52 |
| Volume | 1.23M | Change | +1.20% |
| P/E Ratio | -2.0 | Open | $2.45 |
| Revenue | $18.7M | Prev Close | $2.49 |
| Net Income | $-132.1M | 52W Range | $1.05 - $5.17 |
| Div Yield | N/A | Target | $7.86 |
| Overall | 58 | Value | 60 |
| Quality | 44 | Technical | 72 |
No chart data available
Stock Overview
Updated DailyAclaris Therapeutics Inc. (ACRS) is a leading Healthcare company in the Biotechnology industry, currently trading at $2.52 with a market capitalization of $258.91 million. The stock is in the lower portion of its trading range, demonstrating below-average quality metrics with a MarketXLS quality score of 44.
Today's trading session shows ACRS with a volume of 1.23 million shares. The stock opened down 1.61% from yesterday's close of $2.49. Current analyst estimates project earnings of $-0.51 per share for this year, with next year targeting $-0.54.
ACRS demonstrates strong technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for ACRS include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 211.9%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 07:17 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACRS | $2.52 | +1.2% | 1.23M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Aclaris Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW